NASDAQ · SGRY
Healthcare · Medical - Care Facilities
$23.13
Up+$0.10 (+0.43%)
Updated Nov 4, 2026, 6:25 PM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SGRY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
SGRY closed at $23.13 after 21 trading sessions, up 72.48% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $23.19 | $23.22 | $23.12 | $23.13 | 2.41M |
| Nov 2, 2026 | $23.21 | $23.23 | $23.12 | $23.12 | 3.4M |
| Oct 30, 2026 | $23.24 | $23.245 | $23.19 | $23.21 | 3.51M |
| Oct 29, 2026 | $23.25 | $23.28 | $23.17 | $23.21 | 3.54M |
| Oct 28, 2026 | $23.26 | $23.36 | $23.20 | $23.24 | 3.11M |
| Oct 27, 2026 | $23.20 | $23.37 | $23.13 | $23.36 | 11.2M |
| Oct 26, 2026 | $23.03 | $23.29 | $22.94 | $23.25 | 58.82M |
| Oct 23, 2026 | $15.79 | $16.16 | $15.66 | $15.75 | 3.33M |
| Oct 22, 2026 | $15.52 | $16.00 | $15.345 | $15.90 | 2.91M |
| Oct 21, 2026 | $15.19 | $15.64 | $15.07 | $15.40 | 2.36M |
| Oct 20, 2026 | $14.77 | $15.52 | $14.77 | $15.49 | 4.32M |
| Oct 19, 2026 | $14.57 | $14.89 | $14.49 | $14.71 | 1.31M |
| Oct 16, 2026 | $14.86 | $14.90 | $14.51 | $14.61 | 966.82K |
| Oct 15, 2026 | $15.05 | $15.34 | $14.615 | $14.77 | 2.37M |
| Oct 14, 2026 | $14.46 | $14.84 | $14.085 | $14.83 | 1.44M |
| Oct 13, 2026 | $14.35 | $14.77 | $14.255 | $14.55 | 1.14M |
| Oct 12, 2026 | $13.85 | $14.32 | $13.68 | $14.24 | 1.21M |
| Oct 9, 2026 | $13.69 | $14.06 | $13.605 | $13.89 | 929.01K |
| Oct 8, 2026 | $13.58 | $13.71 | $13.345 | $13.64 | 1.31M |
| Oct 7, 2026 | $13.36 | $13.965 | $13.34 | $13.71 | 1.69M |
| Oct 6, 2026 | $13.43 | $13.57 | $13.22 | $13.41 | 892.29K |
The latest Smart Investors Daily articles mentioning SGRY.
Company
Market Activity
Research & News
SGRY research
Company profile and research snapshot.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 28, 2026 | UBS | Neutral | — |
| Oct 27, 2026 | StoneX | Hold | — |
| Sep 30, 2026 | RBC Capital | Outperform | — |
| Sep 18, 2026 | TD Cowen | Buy | — |
| Sep 14, 2026 | JP Morgan | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 30, 2026
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Yahoo · Oct 29, 2026
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Benzinga · Oct 28, 2026
UBS analyst A.J. Rice downgrades Surgery Partners (NASDAQ:SGRY) from Buy to Neutral and raises the price target from $21 to $23.5.
Yahoo · Oct 27, 2026
HealthSpan, the investment arm of Bon Secours, wants to take Surgery Partners private and absorb its 30-state outpatient footprint.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SGRY.
